Literature DB >> 7419283

Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides.

B Damerau, E Grünefeld, W Vogt.   

Abstract

The highly purified hog complement peptides C3a and C5a and three formylmethionyl peptides induced dose-dependent aggregation of human leukocytes. For the effect Ca2+ and Mg2+ ions were required; in their absence the peptides induced specific desensitization. Human serum albumin (1 and 2%) reduced aggregation, whereas equivalent or even higher concentrations of plasma or serum were not inhibitory. SH reagents, protease inhibitors (N-tosyl-L-lysyl-chloromethyl ketone, N-tosyl-L-phenylalanyl-chloromethyl ketone), and colchicine also inhibited aggregation, whereas cytochalasin B greatly enhanced it. Dose-response studies under comparable conditions showed that aggregation is induced in similar dose ranges as chemotaxis. This suggests that complement-derived peptides generated in vivo may contribute to leukocyte accumulation in two ways, first by causing adherence of leukocytes to endothelium (equivalent to aggregation) and then by promoting migration to the inflammatory site.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7419283     DOI: 10.1159/000232622

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  10 in total

1.  Vascular occlusion of the retina--an experimental model. II. Platelet aggregates.

Authors:  H Schroer; G Scheurer; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 2.  Vascular occlusion of the retina: an experimental model. I. Leukocyte aggregates.

Authors:  G Scheurer; G Praetorius; B Damerau; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Anaphylatoxins inhibit C2 production.

Authors:  D Lappin; B Damerau; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  Defective neutrophil degranulation induced by interleukin-8 and complement 5a and down-regulation of associated receptors in children vertically infected with human immunodeficiency virus type 1.

Authors:  S Meddows-Taylor; L Kuhn; T M Meyers; G Sherman; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

5.  In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

Authors:  T Hoffmann; E C Böttger; H P Baum; M Messner; U Hadding; D Bitter-Suermann
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

6.  Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a.

Authors:  R O Webster; R B Wysolmerski; D Lagunoff
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

7.  Comparison of adhesion to glass and aggregation of human leucocytes.

Authors:  B Damerau; H U Keller
Journal:  Agents Actions       Date:  1983-02

8.  Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro.

Authors:  G Hetland; G J Talgö; M K Fagerhol
Journal:  Mol Pathol       Date:  1998-06

9.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.

Authors:  P J Daffern; P H Pfeifer; J A Ember; T E Hugli
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

10.  Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitro.

Authors:  Z Marom; J Shelhamer; M Berger; M Frank; M Kaliner
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.